Key facts
as of Sep 2026- It has raised $3.4M across 1 recorded rounds; the latest was Seed Round ($3.4M) in Jan 2025.
- Notable investors include New York Ventures, Egret Healthcare Ventures.
- 3 institutional filers report fund marks on Vicora across 5 filings.
- Status: Privately Held (backing).
PA Mark — composite indicative price
LOW confidence~$380per share
as of Sep 2026 · the exact daily mark is a member feature
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Vicora
Create free account
No card required
Recorded secondary trades
No prints on record
No secondary trades in Vicora shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
3 filers · latest Jun 20263 SEC-registered funds reported 5 fair-value marks on Vicora between Mar 2026 and Jun 2026. Filer-level marks and implied $/share are available to Pro members.
Funding rounds
1 roundsAbout Vicora
Manufacturer of a catheter with integrated distal tip vibration intended to treat clots. The company's device focuses on aspiration thrombectomy, improving blood flow, preventing damage to surrounding tissues, to reaching and retrieving the clump among others, enabling medical professionals to have clot removal efficiency.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2020
- Website
- vicora.net/
- Ownership
- Privately Held (backing)